0001708138-21-000049.txt : 20210810
0001708138-21-000049.hdr.sgml : 20210810
20210810175425
ACCESSION NUMBER: 0001708138-21-000049
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210809
FILED AS OF DATE: 20210810
DATE AS OF CHANGE: 20210810
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Van Plew Daniel P
CENTRAL INDEX KEY: 0001411984
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19034
FILM NUMBER: 211161288
MAIL ADDRESS:
STREET 1: REGENERON PHARMACEUTICALS, INC.
STREET 2: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0000872589
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133444607
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
BUSINESS PHONE: 9148477000
MAIL ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
FORMER COMPANY:
FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19930328
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2021-08-09
0
0000872589
REGENERON PHARMACEUTICALS, INC.
REGN
0001411984
Van Plew Daniel P
777 OLD SAW MILL RIVER ROAD
TARRYTOWN
NY
10591
0
1
0
0
EVP & General Mgr, Industrial
Common Stock
2021-08-09
4
M
0
25000
270.43
A
51931
D
Common Stock
2021-08-09
4
F
0
18397
617.68
D
33534
D
Common Stock
2021-08-10
4
S
0
244
606.5
D
33290
D
Common Stock
2021-08-10
4
S
0
762
607.21
D
32528
D
Common Stock
2021-08-10
4
S
0
697
608.5
D
31831
D
Common Stock
2021-08-10
4
S
0
200
609.25
D
31631
D
Common Stock
2021-08-10
4
S
0
100
610.81
D
31531
D
Common Stock
2021-08-10
4
S
0
400
611.57
D
31131
D
Common Stock
2021-08-10
4
S
0
900
612.45
D
30231
D
Common Stock
2021-08-10
4
S
0
1600
613.34
D
28631
D
Common Stock
2021-08-10
4
S
0
1120
614.33
D
27511
D
Common Stock
2021-08-10
4
S
0
280
615.22
D
27231
D
Common Stock
2021-08-10
4
S
0
300
616.27
D
26931
D
Common Stock
1048
I
By 401(k) Plan
Non-Qualified Stock Option (right to buy)
270.43
2021-08-09
4
M
0
25000
0.0
D
2023-12-13
Common Stock
25000
25000
D
Represents volume-weighted average price of sales of 244 shares of Company stock on August 10, 2021 at prices ranging from $606.32 to $606.62. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 10, 2021 at each separate price.
Represents volume-weighted average price of sales of 762 shares of Company stock on August 10, 2021 at prices ranging from $607.00 to $607.84. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 10, 2021 at each separate price.
Represents volume-weighted average price of sales of 697 shares of Company stock on August 10, 2021 at prices ranging from $608.17 to $608.61. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 10, 2021 at each separate price.
Represents volume-weighted average price of sales of 200 shares of Company stock on August 10, 2021 at prices ranging from $609.21 to $609.29. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 10, 2021 at each separate price.
Represents volume-weighted average price of sales of 400 shares of Company stock on August 10, 2021 at prices ranging from $611.22 to $611.85. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 10, 2021 at each separate price.
Represents volume-weighted average price of sales of 900 shares of Company stock on August 10, 2021 at prices ranging from $612.03 to $612.85. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 10, 2021 at each separate price.
Represents volume-weighted average price of sales of 1,600 shares of Company stock on August 10, 2021 at prices ranging from $613.07 to $613.78. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 10, 2021 at each separate price.
Represents volume-weighted average price of sales of 1,120 shares of Company stock on August 10, 2021 at prices ranging from $614.08 to $614.84. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 10, 2021 at each separate price.
Represents volume-weighted average price of sales of 280 shares of Company stock on August 10, 2021 at prices ranging from $615.00 to $615.45. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 10, 2021 at each separate price.
Represents volume-weighted average price of sales of 300 shares of Company stock on August 10, 2021 at prices ranging from $616.01 to $616.51. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 10, 2021 at each separate price.
The stock option award vests in four equal annual installments, commencing one year after the date of grant.
/s/**Daniel P. Van Plew
2021-08-10